Nov 17, 2021 / 04:00PM GMT
Unidentified Analyst -
Hello, and welcome to Deutsche Bank's Depositary Receipts Virtual Investor Conference, DBVIC. My name is (inaudible) from the Deutsche Bank team. I am pleased to announce that our next presentation will be from AstraZeneca PLC from the U.K.
Before I introduce our speaker, a few points to note. Please submit your questions in the questions box below the slides. Once the Q&A session has ended, don't log out. You will automatically be transferred into the AstraZeneca booth where you could continue to ask questions via chat. On a final note, all of today's presentations will be recorded and can be accessed via the Deutsche Bank website, adr.db.com.
At this point, I'm very pleased to welcome Chris Sheldon, Head of Investor Relations; Josie Afolabi, Director, Investor Relations, Oncology; and Christer Gruvris, Director, Investor Relations, Biopharmaceuticals, Finance and Fixed Income of AstraZeneca, which trades on NASDAQ under the symbol AZN and on the London Stock Exchange as AZN. Welcome, Chris, Josie and Christer. Off to you guys.
Christer Gruvris<
AstraZeneca PLC at OTC Markets and Deutsche Bank Depositary Receipts Virtual Investor Conference Transcript
Nov 17, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers